The need to intensify oral diuretic therapy in patients who have heart failure with mildly reduced or preserved ejection fraction (HFmrEF/HFpEF) is significantly decreased with finerenone (Kerendia; ...

Finerenone is already marketed as Kerendia or, in some countries, as Firialta, and approved for the treatment of adult patients with chronic kidney disease (CKD) associated with type 2 diabetes (T2D) ...

Does finerenone improve outcomes in patients withheart failure (HF) with mildly reduced or preserved ejection fraction?

The approval is based on the phase 3 FIDELIO-DKD trial, in which Kerendia (finerenone) reduced the risk of kidney disease progression or renal death by 18% when added to the highest tolerated dose ...

Kerendia (finerenone) is the first drug in its class to show a benefit in heart failure, achieving a statistically significant improvement in cardiovascular outcomes in heart failure patients with ...

Mankind Pharma and other domestic companies have launched generic versions of the popular diabetes drug Empagliflozin at ...

The best Android tablets can do it all. They pack enough power to run apps and games with minimal or no slowdown. They're also energy-efficient enough to last long on a single charge. And when ...

'ZDNET Recommends': What exactly does it mean? ZDNET's recommendations are based on many hours of testing, research, and comparison shopping. We gather data from the best available sources ...

If you're looking for a larger canvas for reading, sketching, gaming, or just about anything else, you're likely much better off going with a tablet. This lets your smartphone keep doing what it ...

Tablets are, effectively, computers. We benchmark tablets against common performance and graphics metrics and run battery life tests for video playback. But we also look at what tablets can do ...